We launched a hepatitis C programme in Cambodia in May 2016, offering the first free treatment for the blood-borne virus in the country. Although the prevalence of the disease is unknown, it is estimated that between 2 and 5 per cent of the population is infected.
The team started by screening HIV patients at the hospital for co-infection; today teams have expanded screening to include patients referred by Preah Kossamak hospital’s hepatology department.
Our malaria research project in northern Cambodia was set up to find ways to eliminate malaria in an area where there is proven resistance to the most powerful antimalarial drug, artemisinin.
MSF teams responded to the coronavirus COVID-19 pandemic in the country between February and June 2020, in which training and technical support was provided in six hospitals.
![Covid-19 Response Covid-19 Response](https://img.msf.org/AssetLink/3k6gjd0ojygodsu37mkw0872f708b20x.jpg)
Innovation needed to respond to COVID-19 in Cambodia
Preparing for COVID-19 in South-East Asia
![MSF has started an intervention for the outbreak of COVID-19 MSF has started an intervention for the outbreak of COVID-19](https://img.msf.org/AssetLink/qnq238l0y27itgb58u5j01q503882eu1.jpg)
Supporting preparedness efforts to fend off coronavirus
![Hepatitis C active case finding Hepatitis C active case finding](https://img.msf.org/AssetLink/ch0b7ah88bo3bp78e3q3em3u0wcho08k.jpg)
Affordable drugs and new hepatitis C treatment method save lives
![Tondo project in Philippines Tondo project in Philippines](https://img.msf.org/AssetLink/0w2wh7xl2q1dc4a8tbf8d63g7a606208.jpg)
A year in pictures 2017
![Hepatitis C - Clinic Cambodia Hepatitis C - Clinic Cambodia](https://img.msf.org/AssetLink/dq2mms65064bm5wh4xiqr68pwut44p1t.jpg)